2012 Economic Outlook - Report Highlights Valeant Pharmaceuticals Int (USA) and The Dow Chemical Company
(firmenpresse) - HONG KONG -- (Marketwire) -- 02/02/12 -- Today, announced new reports highlighting Valeant Pharmaceuticals Int (USA) (NYSE: VRX) and The Dow Chemical Company (NYSE: DOW). Gain market insight with full analysis and research downloads available at .
Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Brighton Markets is releasing new coverage on Valeant Pharmaceuticals Int (USA) for its current position within the healthcare industry. Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. The full research report on Valeant Pharmaceuticals Int (USA) (NYSE: VRX) is available here: .
Brighton Markets has released research on The Dow Chemical Company for its changing role within the basic materials industry. The Dow Chemical Company (Dow) is a diversified manufacturer and supplier of products used primarily as raw materials in the manufacture of customer products and services worldwide. It operates in eight segments. The full research report on The Dow Chemical Company (NYSE: DOW) is available here: .
About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.
Contact:
Jean Barnes
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.02.2012 - 14:00 Uhr
Sprache: Deutsch
News-ID 110393
Anzahl Zeichen: 0
contact information:
Town:
HONG KONG
Kategorie:
Investment Services & Trading
Diese Pressemitteilung wurde bisher 205 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"2012 Economic Outlook - Report Highlights Valeant Pharmaceuticals Int (USA) and The Dow Chemical Company"
steht unter der journalistisch-redaktionellen Verantwortung von
Brighton Markets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
